ERBB2 and neoplasm: Even though both ER+ (P=0.002) and ER- (P=0.001) tumours exhibit a significant higher HER2 mRNA levels in HER2 amplified compared to non-amplified tumours, the difference in HER2 mRNA levels between amplified and non-amplified tumours were most evident among ER- tumours (Figure 1A).